Showing 81-90 of 3024 results for "".
Promising Directions in Relapse-Impact Prevention in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/promising-directions-in-relapse-impact-prevention-in-multiple-sclerosis/30520/Current immunomodulatory treatments for MS are not reliable to prevent long-term disability, but future agents focusing on remyelination and axonal and neuronal repair could reverse this course.Relapsing and Progressive Multiple Sclerosis: Understanding the Differences
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/relapsing-and-progressive-multiple-sclerosis-understanding-the-differences/30761/Accurate diagnosis is important in order to adjust treatment according to MS type as wells as individual response.Vitamin D: Considerations for Treatment, Prevention, and Risk in Multiple Sclerosis Care
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/vitamin-d-considerations-for-treatment-prevention-and-risk-in-multiple-sclerosis-care/30373/Preliminary signals are strong that vitamin D has a role to play in MS, but more research is needed to confirm the need for supplementation as a preventive or therapeutic measure.The Importance of Early Diagnosis and Treatment of Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/the-importance-of-early-diagnosis-and-treatment-of-alzheimer-disease/35436/Linda Shows, a semi-retired nurse who lives with mild cognitive impairment, and her physician, Wendell Helveston, MD, Hattiesburg Clinic, Hattiesburg, MS, discuss the importance of early diagnosis and treatment in Alzheimer disease, including other factors that can help patients thrive when living wThe Use of Intracranial Vessel Wall MRI for the Diagnosis of Vasculitis
https://practicalneurology.com/diseases-diagnoses/stroke/the-use-of-intracranial-vessel-wall-mri-for-the-diagnosis-of-vasculitis/37234/Jae W. Song, MD, MS, Associate Professor of Radiology at the University of Pennsylvania, Philadelphia, PA, discusses the diagnostic value of intracranial vessel wall MRI for vasculitis, as well as when clinicians should order this imaging technique and the challenges that may arise.- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31238/Differentiating Multiple Sclerosis (MS) from Sjögren’s Syndrome (SS) is critical due to overlapping neurological manifestations and distinct treatment pathways. A clinical case of a 49-year-old woman presenting with ataxia and band-like paresthesias initially suggests MS, supported by MRI findings o
Maturing with Migraine: Practical Guidelines for Transitioning Adolescent Migraine and Headache Patients into Adult Practice
https://practicalneurology.com/diseases-diagnoses/headache-pain/maturing-with-migraine-practical-guidelines-for-transitioning-adolescent-migraine-and-headache-patients-into-adult-practice/48903/Hope O’Brien, MD, MBA, FAHS, FAAN, Founder and CEO of the Headache Center of Hope, Cincinnati, OH, discusses challenges and considerations for adult headache neurologists who are onboarding adolescent patients as they transition from pediatric practice. Dr. O’Brien highlights a framework with strate- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31137/Clinical Insights: Recent Advances in NeurologyRecent genetic studies continue to illuminate the complex interplay between genetics and multiple sclerosis (MS). A genome-wide association study published in the *New England Journal of Medicine* identified heritable risk factors for MS, specifically a
Men With Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/men-with-multiple-sclerosis/31758/Men with MS comprise an unlikely minority with distinct challenges that may also intersect with other signifiers of special populations.Multiple Sclerosis in People Over Age 55
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-in-people-over-age-55/31759/The average age of people with MS is increasing, but knowledge of the disease in people over age 55 remains sparse.